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Purpose: The Upper Limb Physician’s Rating Scale (ULPRS) is a tool that assesses 
movement quality of the upper limbs. It is used as an outcome measure after botuli-
num toxin type A injection in children with cerebral palsy (CP). This study aimed to 
investigate the reliability and validity of the ULPRS in children with spastic CP. Ma-
terials and Methods: Thirty children with spastic CP (M:F=17:13) aged 5 to 13 
years old were recruited. The ULPRS was scored based on recorded videotapes by 
four physicians on two separate occasions. The Melbourne Assessment of Unilateral 
Upper Limb Function (MUUL) was scored by an occupational therapist. Intraclass 
correlation coefficients (ICCs), 95% confidence intervals and weighted kappa statis-
tics were calculated for the scores of ULPRS to obtain interrater and intrarater reli-
ability. The relationship between ULPRS and MUUL was assessed using Pearson 
correlation coefficients. Results: The ICCs for the total ULPRS scores were 0.94 be-
tween raters and 0.99 to 1.00 within raters. The weighted kappa statistics for subitem 
scores for the ULPRS ranged from 0.67 to 1.00 within raters and from 0.46 to 0.86 
between raters. The relationship between ULPRS and MUUL was strong (Pearson 
correlation coefficient=0.751; p<0.05). Conclusion: The results demonstrated the 
high reliability of the total ULPRS score within and between raters. A significant 
concurrent validity between ULPRS and MUUL also supports the clinical utility of 
the ULPRS as an outcome measure of spastic upper limb in children with CP.
Key Words:   Upper extremity, botulinum toxin type A injection, outcome mea-
sure, Melbourne assessment, unilateral upper limb function
INTRODUCTION
Cerebral palsy (CP) is the most common neurologic disorder that causes chronic 
motor disability in children.1 The majority of CP cases are of the spastic type, and the 
upper limb is commonly involved. Spasticity has been considered a main contributor 
to both impairment of function and the development of deformity. Thus, reduction of 
spasticity plays an important role in managing children with spastic CP. Botulinum 
toxin type A (BoNT-A) injection into spastic upper limb muscles has been widely 
used as an adjunct to conventional therapeutic techniques as a means of reducing 
muscle spasticity and improving function in the affected arm.2 A reduction of muscle 
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ability of the ULPRS in children with spastic cerebral palsy 
and 2) to examine the concurrent validity of the ULPRS by 
investigating its relationship with the MUUL.
MATERIALS AND METHODS
Participants
Thirty children with spastic CP (M:F=17:13) were recruit-
ed. The Gross Motor Function Classification System (GM-
FCS) is widely used to assess the gross motor function in 
children with CP, and the Manual Ability Classification Sys-
tem (MACS) was developed to evaluate a child’s typical 
manual performance in daily life.14,15 GMFCS and MACS 
levels of the participants and the distributions of sex, age, 
and involvement are shown in Table 1. 
Ethical approval was granted by the Institutional Review 
Board and Ethics Committee of Severance Hospital (#4-
2012-0265). Because all of the children in this study were 
younger than 18 years, informed consent was obtained from 
the parents of the children for their participation in the study. 
Measurements
All of the children were videotaped so that physicians could 
assess the ULPRS of the upper arm while specific tasks 
were performed. One physician gave instructions and dem-
onstrated the movements while the other physician record-
ed the videotape. The scoring of the ULPRS from the video-
tape was completed by 4 physicians on 2 separate occasions 
with a time interval of at least one week. The score sheet in-
cludes 9 items, and 3-, 4-, and 5-point scales are used to 
score each component of movement tested.
The MUUL for the affected or more severely affected 
upper limb was scored by one occupational therapist. 
Statistical analysis
Missing values on items scores were handled in the analysis 
as follows: 1) for single-item summaries of reliability, par-
ticipants with missing values were omitted, and 2) for analy-
sis based on total scores, mean substitution was used so that 
for each child, their total score was equal to the average on 
the non-missing items rescaled to the total number of items 
recorded.
The intrarater and interrater reliability of the total ULPRS 
scores were examined using intraclass correlation coeffi-
cients (ICCs, based on a two-way random effects model with 
absolute agreement). To calculate interrater and intrarater re-
tone, changes in movement pattern, and also an improve-
ment in upper limb function following BoNT-A injection 
has been described using various outcome measures.3-7
The Upper Limb Physician’s Rating Scale (ULPRS) is a 
semi-quantitative modification of the Lower Limb Physi-
cian’s Rating Scale. It was designed to assess changes in 
the movement pattern, focusing on all 3 levels of the arm 
(palm, forearm, and elbow) to determine whether there is 
an isolated functional impairment, such as thumb in palm, 
restricted forearm supination, or a total flexion pattern with 
thumb in palm, wrist in flexion, forearm supinated, and el-
bow flexed (Supplementary Table 1, only online).2,8,9 
The ULPRS has been recommended by previous studies 
as an outcome measure to assess functional measures and 
changes in the movement pattern following BoNT-A injec-
tion.2,8,10 The merits of ULPRS are its ease of use in mea-
suring spasticity and speed of assessment by a variety of 
health care providers without special training. Thus, it may 
be suitable as an outcome measure for periodic assessments 
in a busy office setting. However, the reliability and validity 
of ULPRS have not yet been investigated. 
The Melbourne Assessment of Unilateral Upper Limb 
Function (MUUL) is a reliable and valid tool for measuring 
the quality of upper limb movement in children aged 5 to 15 
years with cerebral palsy.11,12 It is widely used to examine the 
effectiveness of specific therapeutic interventions. In addi-
tion, it was considered the best measure of unimanual capac-
ity in a systematic review article.13 However, to our knowl-
edge, there is no information about the relationship between 
ULPRS and MUUL. We hypothesized that the ULPRS 
would be a reliable clinical test for assessing upper limb 
function in children with CP. Therefore, the aims of this 
study were: 1) to evaluate the intrarater and interrater reli-
Table 1. Characteristics of Participants
Mean±SD 
(range) 
Sex (M:F) 17:13
Age (yrs) 8.3±3.0 (5‒13)
Involvement (bilateral:unilateral) 24:6
Dominant hand (right:left) 10:20
GMFCS level (n=30, I:II:III:IV:V) 4:5:8:9:4
    In unilateral involvement (n=24, I:II:III:IV:V) 3:2:1:0:0
    In bilateral involvement (n=6, I:II:III:IV:V) 1:3:7:9:4
MACS level (n=30, I:II:III:IV:V) 3:14:10:3:0 
    In unilateral involvement (n=24, I:II:III:IV:V) 1:4:0:1:0
    In bilateral involvement (n=6, I:II:III:IV:V) 2:10:10:2:0
GMFCS, gross motor functional classification system; MACS, manual abil-
ity classification system.
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interrater and intrarater reliability (Table 3). 
The weighted kappa statistics for ULPRS subitem scores 
ranged from 0.67 to 1.00 within raters. The k values for intr-
arater reliability were excellent except for subitems of finger 
opening, thumb in palm, and associated increase in muscle 
tone for Rater 3, and active supination in flexion and exten-
sion for Rater 4. On the other hand, weighted kappa statis-
tics for subitems of ULPRS ranged from 0.46 to 0.86 be-
tween raters. The k values between raters were excellent for 
only 1 subitem and substantial for 4 ULPRS subitems (Ta-
ble 4). Fig. 1 displays the differences in the total ULPRS 
scores between occasions for each rater. The means and 
95% limits of agreement (LOA) between occasions were 
0.03±1.54 for Rater 1, -0.03±3.37 for Rater 2, -0.13±2.79 
for Rater 3, and 0.03±1.54 for Rater 4. As shown in Fig. 1, 
there were no obvious outliers. 
The relationship between the ULPRS and MUUL was 
strong (Pearson correlation coefficient=0.751; p<0.05).
DISCUSSION
There are various measures to assess upper arm function in 
liability of the subitems of the ULPRS (ordinal data), we 
used linearly weighted kappa statistics. ICCs and 95% con-
fidence intervals (95% CI) were calculated using SPSS 
software 19.0 for Windows (SPSS Inc., Chicago, IL, USA). 
The goal of this analysis was to describe the relative homo-
geneity of the scores with data sets16 and to indicate the de-
gree of agreement between ratings provided by multiple 
raters.17 Measures from trials 1 and 2 for each rater were 
compared to determine intrarater reliability. Trial 1 for each 
rater was used to assess interrater reliability. To further exam-
ine reliability, the correlation coefficients were used to calcu-
late the standard error of measurement (SEM), which was 
calculated on the basis of inter-value differences and standard 
deviation. The SEMs were calculated for the ULPRS by us-
ing the following formula: SEM%=SD·√(1-ICC)×(1/mean)× 
100.17 The consistency of measurements between occasions 
for the total ULPRS score for each physician was examined 
using the method of Bland and Altman.18 
Interpretation of the ICCs was as follows: values above 
0.80 were considered very high, between 0.60 and 0.79 
were moderately high, between 0.40 and 0.59 were moder-
ate, and less than 0.40 were low.19 There were no absolute 
criteria for acceptable reliability; however, ICCs greater than 
0.7 were considered reliable for sample-based research.20
According to the guidelines of Landis and Koch,21 kappa 
values of more than 0.80 were considered excellent, between 
0.61 and 0.80 were substantial, between 0.40 and 0.60 were 
moderate, and less than 0.40 were poor to fair.
To examine the concurrent validity of ULPRS, the rela-
tionship between the total ULPRS and MUUL scores was 
tested using the Pearson correlation coefficient. 
 
RESULTS
 
The mean ULPRS scores performed by four physicians on 
two different occasions, the ULPRS score at each reading 
and the mean score for the MUUL are listed in Table 2. 
There were no missing values among the data. 
The ICCs for the total ULPRS scores were 0.94 between 
raters and 0.99 to 1.00 within raters, indicating very high 
Table 2. ULPRS and MUUL Scores 
Mean±SD (Range, SEM%)
ULPRS 35.0±10.5 (8.7‒46.1, 5.5)
    Rater 1 
        Trial 1 33.7±11.3 (9‒47, 6.1)
        Trial 2 33.6±11.4 (9‒47, 6.2)
    Rater 2
        Trial 1 34.1±10.4 (6‒47, 5.6)
        Trial 2 34.2±10.9 (6‒47, 5.8)
    Rater 3 
        Trial 1 37.1±10.3 (7‒47, 5.1)
        Trial 2 37.1±10.2 (5‒47, 5.0)
    Rater 4 
        Trial 1 35.2±10.6 (7‒47, 5.5)
        Trial 2 35.2±10.4 (7‒47, 5.4)
MUUL 84.3±35.1 (7‒128)
SD, standard deviation; ULPRS, Upper Limb Physician’s Rating Scale scor-
ing; MUUL, Melbourne Assessment Unilateral Upper Limb Function; SEM, 
standard error of measurement.
Table 3. Interrater and Intrarater Reliability as Assessed by Intra-Class Correlation Coefficients (ICC) with 95% CI for the Total 
Scores on the ULPRS 
Subitems Interrater reliability 
ICC (95% CI)
Intrarater reliability ICC (95% CI)
Rater 1 Rater 2 Rater 3 Rater 4
  Total score 0.94 (0.90‒0.97) 1.00 (1.00‒1.00) 0.99 (0.99‒1.00) 1.00 (0.99‒1.00) 0.99 (0.99‒1.00)
CI, confidence interval; ULPRS, Upper Limb Physician’s Rating Scale scoring.
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of administration are crucial for periodic assessments. The 
ULPRS is a simple tool for assessing the quality of move-
ment and function that can be performed by a variety of 
health care providers, and its ease of application can be use-
ful in a busy clinical setting. In our study, the ICCs of the 
total ULPRS score were over 0.9 for both intrarater and in-
terrater reliability, which indicates strong reliability of the 
total ULPRS score. As far as we know, this is the first study 
to investigate the reliability of the ULPRS. The ICCs for in-
terrater and intrarater reliability of the total ULPRS score in 
children with CP, such as the Quality of Upper Extremity 
Skills Test (QUEST),22 the MUUL,11 the Assisting Hand As-
sessment (AHA)23 and the Shriners Hospital Upper Extrem-
ity Evaluation (SHUEE),24 which differ in terms of which 
aspect of upper limb function and which age range they tar-
get. Therefore, clinicians may select an upper limb measure-
ment tool to assess a specific aspect of upper limb function. 
The reliability and validity of an assessment tool is impor-
tant in effectively measuring the outcomes of a specific 
therapeutic intervention. In addition, convenience and ease 
Table 4. Intrarater Reliability as Assessed by Intra-Class Correlation Coefficients (ICC) with 95% Confidence Intervals (CI) and 
Intrarater Reliability as Assessed by Weighted Kappa Statistics for Individual Subitem Scores on the ULPRS
Subitems Interrater reliability 
(weighted kappa) 
Intrarater reliability (weighted kappa)
Rater 1 Rater 2 Rater 3 Rater 4
Active elbow extension 0.79 0.90 0.95 0.87 0.89
Active supination in extension 0.86 0.95 1.00 0.81 0.77
Active supination in flexion 0.75 0.95 0.95 0.84 0.67
Active wrist dorsiflexion 0.71 0.95 0.90 0.94 0.90
Wrist dorsiflexion 0.47 0.90 0.84 0.88 0.88
Finger opening 0.60 1.00 0.94 0.68 1.00
Thumb in palm 0.63 1.00 0.91 0.69 0.90
Associated increase in muscle tone 0.46 0.95 0.90 0.73 1.00
Two-handed function 0.50 0.95 0.90 0.88 1.00
ULPRS, Upper Limb Physician’s Rating Scale scoring.
Fig. 1. Repeat score differences for each rater. Mean: repeat score mean; difference: repeat-score difference; dotted line: median of repeat-score differ-
ence; middle solid line: mean of repeat-score difference; top and bottom solid line: 95% limits of agreement for the repeat-score difference. 
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cant positive correlation between total ULPRS and MUUL 
scores in our study indicates that the two scales may be 
comparable. 
According to the International Classification of Function-
ing, Disability and Health (ICF), upper limb function can be 
measured based on body impairment, activity, and participa-
tion levels. The MUUL is a tool for assessing the activity lev-
el of ICF, whereas the ULPRS has components representing 
impairment levels of ICF in addition to activity levels. Dif-
ferences in the way components of ICF were measured may 
have contributed to the weaker relationship between the UL-
PRS and MUUL.
Changes in movement pattern and quality after BoNT-A 
injection are of interest to clinicians involved in the manage-
ment of spastic upper limbs. From this perspective, the UL-
PRS may have unique clinical value and thus is often used 
as an outcome measure following BoNT-A injection in the 
literature.2,8,10 The acceptable reliability, reproducibility, and 
also validity of the ULPRS demonstrated in our study sup-
port the clinical use of the ULPRS as an upper arm mea-
sure for children with spastic CP following BoNT-A injec-
tion into spastic upper limb muscles.  
Videotaped evaluation of upper extremity function has 
several advantages as well as certain disadvantages. One ad-
vantage is the ability to observe the same performance sev-
eral times to capture movement quality more accurately. On 
the other hand, the procedure is time-consuming, and scor-
ing from video clips using the ULPRS may be difficult de-
pending on the angle of the video. Therefore, intrarater and 
interrater reliability from videotaped performances of upper 
extremity function in children with CP may differ from reli-
ability measured live. Comparison of reliability between live 
and video observation is needed.
In addition, the ULPRS originally aimed to measure post-
intervention changes; however, therapeutic interventions 
were not involved in our study, the effectiveness of the UL-
PRS in this situation was not examined. Further study is 
needed to demonstrate the validity of measuring post-inter-
vention changes.
Our study demonstrated high ICC values within and be-
tween raters for the total ULPRS score and also a strong re-
lationship between the ULPRS and MUUL. These findings 
support the clinical utility of ULPRS as an outcome mea-
sure after spastic management of the upper limb. However, 
k values for subitem scores within and between raters varied 
from excellent to moderate agreements. Further efforts are 
required to provide scoring guidelines that clarify the differ-
our study are compatible with those of QUEST and MUUL 
in the literature, which are commonly used to assess upper 
arm function for children with CP.11,22,25
As for the intrarater reliability of the ULPRS item scores, 
the weighted kappa statistics were overall excellent except 
for 3 subitems for Rater 3 and 2 subitems for Rater 4. On 
the other hand, the interrater reliability for ULPRS subi-
tems varied from excellent to moderate agreement. In addi-
tion, there were no obvious outliers on the Bland-Altman 
plot, which was narrow. The LOA indicated that the agree-
ment was strong, with the 95% LOA range within ±3.37 on 
a 47-point scale. These findings suggest that differences in 
the ULPRS of more than 3.37 after intervention when per-
formed by the same rater may reflect a true change in func-
tion as a result of therapeutic intervention.
The ICCs for each item of the ULPRS are in accordance 
with the reliability of each score on the MUUL in previous 
studies, where the ICCs varied from low to high (ranging 
from 0.37 to 0.91).26,27 Some reports demonstrated that the 
reliability of the scores on each item of the MUUL were ac-
ceptable for all items except items 1 and 2.11,26 In contrast, 
only 9 of 16 items of the MUUL achieved ICCs over 0.7 in 
Spirtos, et al.’s27 report. Although the reason for this signifi-
cant difference was not clear, differences in the severity of 
the subjects’ cerebral palsy have been suggested as a possi-
ble reason in the Spirtos study. In our study, the weighted 
kappa statistics for only 4 of 9 items were greater than 0.7. 
The elbow flexors, pronators, and wrist flexors are common-
ly targeted for spastic upper limb management with BoNT-A 
injection,10 and thus, our results indicate that changes in 
movement patterns after BoNT-A injection into those mus-
cles may be reliably measured with the ULPRS. However, 
ICCs for the five remaining items on the ULPRS were not 
adequate for clinical use; therefore, scoring guidelines for 
clarifying differences between individual scoring criteria 
are needed.
The MUUL is based on 16 items comprising of tasks that 
are representative of the most important components of uni-
lateral upper limb function (reach, grasp, release, and ma-
nipulation).28 The test is administered by a therapist, with a 
video recording of the child’s performance obtained for sub-
sequent scoring. The reliability and validity of the MUUL 
has been well-established in previous studies.12,26,27 Accord-
ing to a recent systematic review article, MUUL is the best 
scale to measure unimanual functional changes as a result 
of spasticity management.13 Therefore, the validity of the 
ULPRS was assessed in relation to the MUUL. The signifi-
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Supplementary Table 1. Upper Limb Physician’s Rating Scale
Parameters Definitions
Active elbow extension (normal 180°)
>10° reduction 0 0
1 to 10° reduction 1 1
No reduction 2 2
Active supination in extension 
  (Elbow extended, forearm supinates)
  Mid-position: palm to 90° horizontal
None 0 0
Under mid-position 1 1
To mid-position 2 2
Past mid-position 3 3
Active supination in flexion 
  (elbow flexed at 90° forearm supinates)
None 0 0
Under mid-position 1 1
To mid-position 2 2
Past mid-position 3 3
Active wrist dorsiflexion 
  (forearm supported, active dorsiflexion of wrist)
  Mid-position: palm level with forearm
None 0 0
Under mid-position 1 1
To mid-position 2 2
Past mid-position 3 3
Wrist dorsiflexion 
  (angle of movement)
Wrist ulnar deviation 0 0
Wrist radial deviation 1 1
Neutral 2 2
Finger opening
Only wrist flexion 0 0
With wrist in neutral position 1 1
With wrist dorsiflexion 2 2
Thumb in function 
Within palm 0 0
Pressed laterally against index finger 1 1
Partly assist in grasp 2 2
Thumb finger grasp possible 3 3
Active abduction 4 4
Associated increase in muscle tone
In all manipulative functions 0 0
Only with fine motor manipulation 1 1
Only with walking or running 2 2
None 3 3
Two handed function
None 0
Poor, no use of hidden function 1
Use of all functions, but limited in ADLs 2
Use of all functions, but not limited in ADLs 3
Total score  47
ADL, activity of daily living.
Adapted from Graham HK, et al. Gait Posture 2000;11:67-79.2 
